Meeting Abstract


DOI :10.26650/JARHS2021-1135821   IUP :10.26650/JARHS2021-1135821    Full Text (PDF)

DATA SCIENCE, CANCER AND SEQUENCING ANALYSES

Mehmet Baysan

Recent developments in technology led to exponential growth in processing speed, storage capacities and communication rates. These available resources allowed the creation of thousands of applications that run on smart devices and the world wide web. Today we generate lots of data using these applications and the availability of vast digital data created a new field: data science. Data science aims to utilize digital data to develop solutions to improve human life. Next-generation sequencing technologies enabled the generation of high-throughput genomic data from DNA and RNA. Considering the great potential for genomic data to understand biological functions and the substantial drop in sequencing costs; the amount of available data increased exponentially over time. Sequencing technologies are based on the shredding of the DNA and capture of short reads. These reads are then combined to identify the genomic map of the biological sample. Some of our studies are based on extraction of multiple samples from a tumor and application of sequencing on these samples to understand the tumor development, progression and drug response. Unfortunately, all the frequently used analysis algorithms are based on optimistic assumptions. High level of disparity is observed in literature and in our studies when we compare different algorithms. Currently, we do extensive testing on realistic scenarios to understand the sources of variation in the results. Finally, we develop a user-friendly analysis platform for comparative sequencing analyses to enhance the cooperation among scientists with different backgrounds on sequencing projects.


PDF View

References

    Citations

    Copy and paste a formatted citation or use one of the options to export in your chosen format


    EXPORT



    APA

    Baysan, M. (2022). DATA SCIENCE, CANCER AND SEQUENCING ANALYSES. Journal of Advanced Research in Health Sciences, 5(1), 21-21. https://doi.org/10.26650/JARHS2021-1135821


    AMA

    Baysan M. DATA SCIENCE, CANCER AND SEQUENCING ANALYSES. Journal of Advanced Research in Health Sciences. 2022;5(1):21-21. https://doi.org/10.26650/JARHS2021-1135821


    ABNT

    Baysan, M. DATA SCIENCE, CANCER AND SEQUENCING ANALYSES. Journal of Advanced Research in Health Sciences, [Publisher Location], v. 5, n. 1, p. 21-21, 2022.


    Chicago: Author-Date Style

    Baysan, Mehmet,. 2022. “DATA SCIENCE, CANCER AND SEQUENCING ANALYSES.” Journal of Advanced Research in Health Sciences 5, no. 1: 21-21. https://doi.org/10.26650/JARHS2021-1135821


    Chicago: Humanities Style

    Baysan, Mehmet,. DATA SCIENCE, CANCER AND SEQUENCING ANALYSES.” Journal of Advanced Research in Health Sciences 5, no. 1 (Feb. 2024): 21-21. https://doi.org/10.26650/JARHS2021-1135821


    Harvard: Australian Style

    Baysan, M 2022, 'DATA SCIENCE, CANCER AND SEQUENCING ANALYSES', Journal of Advanced Research in Health Sciences, vol. 5, no. 1, pp. 21-21, viewed 24 Feb. 2024, https://doi.org/10.26650/JARHS2021-1135821


    Harvard: Author-Date Style

    Baysan, M. (2022) ‘DATA SCIENCE, CANCER AND SEQUENCING ANALYSES’, Journal of Advanced Research in Health Sciences, 5(1), pp. 21-21. https://doi.org/10.26650/JARHS2021-1135821 (24 Feb. 2024).


    MLA

    Baysan, Mehmet,. DATA SCIENCE, CANCER AND SEQUENCING ANALYSES.” Journal of Advanced Research in Health Sciences, vol. 5, no. 1, 2022, pp. 21-21. [Database Container], https://doi.org/10.26650/JARHS2021-1135821


    Vancouver

    Baysan M. DATA SCIENCE, CANCER AND SEQUENCING ANALYSES. Journal of Advanced Research in Health Sciences [Internet]. 24 Feb. 2024 [cited 24 Feb. 2024];5(1):21-21. Available from: https://doi.org/10.26650/JARHS2021-1135821 doi: 10.26650/JARHS2021-1135821


    ISNAD

    Baysan, Mehmet. DATA SCIENCE, CANCER AND SEQUENCING ANALYSES”. Journal of Advanced Research in Health Sciences 5/1 (Feb. 2024): 21-21. https://doi.org/10.26650/JARHS2021-1135821



    TIMELINE


    Published Online09.08.2022

    LICENCE


    Attribution-NonCommercial (CC BY-NC)

    This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


    SHARE




    Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.